Rankings
▼
Calendar
CMMB Q1 2023 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$9M
Operating Income
-$9M
Net Income
-$9M
EPS (Diluted)
$-3.14
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$35M
Total Liabilities
$7M
Stockholders' Equity
$28M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$9M
-$13,028
-69358.1%
Operating Income
-$9M
-$5M
-70.4%
Net Income
-$9M
-$5M
-71.5%
← FY 2023
All Quarters
Q2 2023 →